
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Glatiramer Acetate
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
ScinoPharm Gets US FDA Nod for Glatiramer Acetate Injection in Multiple Sclerosis
Details : Glatiramer Acetate, a miscellaneous product targeting polymers, shows promise in treating Multiple Sclerosis (MS).
Product Name : Copaxone-Generic
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
January 05, 2026
Lead Product(s) : Glatiramer Acetate
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
